Equities

Advanced Medical Solutions Group PLC

AMS:LSE

Advanced Medical Solutions Group PLC

Health CareMedical Equipment and Services
  • Price (GBX)217.00
  • Today's Change-0.50 / -0.23%
  • Shares traded668.57k
  • 1 Year change5.85%
  • Beta0.8374
Data delayed at least 20 minutes, as of Feb 06 2026 17:08 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Advanced Medical Solutions Group plc is an independent developer and manufacturer of tissue-healing technology, focused on quality outcomes for patients. Its surgical products, including tissue adhesives, suture, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, Peters Surgical, Ifabond, Vitalitec and Seal-G. It also supplies wound care dressings, such as silver alginates, alginates and foams through its ActivHeal brand, and under white label. Its Surgical Business Unit includes tissue adhesives, sutures, biosurgical devices and internal fixation devices. The Woundcare Business Unit comprises a multi-product portfolio of advanced woundcare dressings and a portfolio of specialist medical bulk materials and multi-layer woundcare and bio-diagnostics products. Its products are manufactured in the United Kingdom, Germany, France, the Netherlands, Thailand, India, the Czech Republic and Israel.

  • Revenue in GBP (TTM)220.30m
  • Net income in GBP9.12m
  • Incorporated1993
  • Employees1.50k
  • Location
    Advanced Medical Solutions Group PLCPremier Park, 33 Road OneWINSFORD CW7 3RTUnited KingdomGBR
  • Phone+44 16 0686 3500Fax+44 16 0686 3600
  • Websitehttps://www.admedsol.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Medistim ASA50.68m10.80m297.46m154.00297.46m154.00
COLTENE Holding AG227.93m13.55m310.64m1.18k310.64m1.18k
CellaVision AB60.93m12.33m316.50m230.00316.50m230.00
IVF Hartmann Holding AG150.98m18.01m338.61m309.00338.61m309.00
Ion Beam Applications SA517.89m14.76m398.49m2.10k398.49m2.10k
Lumibird SA187.45m9.31m436.84m1.07k436.84m1.07k
Revenio Group Oyj94.63m16.06m446.52m248.00446.52m248.00
RaySearch Laboratories AB (publ)105.14m17.84m448.81m450.00448.81m450.00
medmix AG443.25m-5.49m457.14m2.67k457.14m2.67k
Advanced Medical Solutions Group plc220.30m9.12m476.50m1.50k476.50m1.50k
Xvivo Perfusion AB66.12m2.05m515.43m198.00515.43m198.00
Synektik SA108.45m19.47m524.74m203.00524.74m203.00
Arjo AB (publ)895.57m27.19m561.11m6.94k561.11m6.94k
GVS SpA366.67m19.85m678.19m4.23k678.19m4.23k
Paul Hartmann AG2.11bn70.75m691.52m10.09k691.52m10.09k
Data as of Feb 06 2026. Currency figures normalised to Advanced Medical Solutions Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

38.16%Per cent of shares held by top holders
HolderShares% Held
Octopus Investments Ltd.as of 15 Oct 202524.12m10.99%
Canaccord Genuity Wealth Ltd.as of 30 Apr 202514.40m6.56%
Raymond James Wealth Management Ltd. (Investment Management)as of 02 May 20259.02m4.11%
Rathbones Investment Management Ltd.as of 30 Apr 20257.17m3.27%
Invesco Asset Management Ltd.as of 30 Apr 20256.55m2.98%
AXA Investment Managers UK Ltd.as of 27 Mar 20255.59m2.55%
Briarwood Chase Management LLCas of 04 Apr 20254.78m2.18%
Brooks Macdonald Asset Management Ltd.as of 23 Apr 20254.25m1.93%
BlackRock Fund Advisorsas of 03 Nov 20253.95m1.80%
Chelverton Asset Management Ltd.as of 31 Mar 20253.94m1.79%
More ▼
Data from 31 Jul 2025 - 20 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.